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ABSTRACT 
Background 
Uncontrolled asthma and chronic obstructive airway disease (COPD) is a frequent cause of 
emergency department visits and hospital admissions. Poor metered dose inhaler (MDI) 
technique is likely a major contributory cause. 
 
Objectives 
This study evaluated study participants' knowledge of MDI technique, and their compliance 
in checking and demonstrating MDI use, to patients on inhaled therapy. 
 
Methods 
A questionnaire was administered to doctors, nurses, and final year medical students at Helen 
Joseph Hospital and Chris Hani Baragwanath Academic Hospital in the Departments of 
Internal Medicine, Emergency Medicine and Pulmonology. Participants' use of a placebo 
MDI was also evaluated by a scoring system. 
 
Results 
The total sample of 195 participants comprised 130 (67%) females and 65 (33%) males. Of 
these, 133 (68%) were qualified medical staff, and 62 were final year medical students. 
Only 32 (16%) had adequate MDI technique. Over 50% of participants did not demonstrate 
MDI technique to patients, or check their patients' technique. 
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Conclusion 
Health care professionals (HCPs) and final year medical students have poor knowledge of 
inhaler technique and are ill-prepared to teach patients. Also of concern is that the majority 
do not routinely demonstrate or observe patients’ inhaler technique. 
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CHAPTER 1: PROTOCOL AND EXTENDED LITERATURE REVIEW 
 
1. 1 Introduction and Background  
The prevalence of chronic airway disease is increasing in all parts of the globe. Three 
hundred million people have asthma and 210 million people have chronic obstructive 
pulmonary disease (COPD) worldwide.1-2 
 
1. 2 Asthma 
1. 2.1 Definition 
Asthma is defined as a chronic inflammatory disease of the airway. It is characterized by 
reversible narrowing of the airway, resulting in obstruction of airflow in susceptible 
individuals, secondary to exposure to a stimulus e.g. cold air, dust mites, air pollutants, and 
even anxiety. The WHO defines asthma as an inflammatory disease characterized by 
recurrent attacks of breathlessness and wheezing.3Itis a complex interaction of airflow 
obstruction and bronchial hyper-responsiveness. The severity and frequency of attacks varies 
from individual to individual.3 
 
1. 2.2 Pathogenesis 
Genetics play an important role in the development and maintenance of asthma. There is a 
higher concordance in twins, and similarly an increased incidence in first degree relatives. 
Atopy predisposes individuals to develop animmunoglobulin E (IgE)-mediated response to 
common inhaled allergens. It is also the strongest identifiable predisposing factor for 
developing asthma.4-5 
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In asthma, exposure to allergens or known triggers, results in immunohistopathological 
changes to the bronchial mucosa. There is a significant influx of inflammatory cells such as 
eosinophils, lymphocytes, mast cells and neutrophils (especially in acute, fatal attacks and 
smokers), leading to epithelial cell injury. Structurally, there is thickening of the bronchial 
wall and narrowing of the bronchial lumen. Ongoing inflammation contributes to airway 
hyper-reactivity and hyper-responsiveness, decreased airway patency due to airway oedema, 
chronic respiratory symptoms which can lead to an acute asthmatic attack and ultimately, 
airway wall remodelling.4-5 
 
Asthma should be treated early and appropriately. This prevents continuous changes to 
airway structure resulting in sub-basement membrane fibrosis, increased mucus secretion 
with formation of mucus plugs, smooth muscle hypertrophy and formation of new blood 
vessels that proliferate and dilate abnormally. Airway repair is not well regulated.4-5This 
contributes to the chronicity of asthma as well as to limitation in therapeutic response.5 
 
1. 2.3 Asthma related complications 
Severe, uncontrolled asthma may lead to recurrent emergency department visits as well as 
hospitalization. This impacts negatively on quality of life with increased number of sick days 
from work or school, and inability to take part in recreational activities. 
 
The structural changes that occur with asthma, i.e. narrowing of the airways and mucus 
hyper-secretion, affect how well an individual can breathe and may lead to respiratory failure. 
In rare cases, asthma may lead to life-threatening respiratory complications such as 
pneumothorax with lung collapse which can be fatal. This requires urgent insertion of an 
intercostal drain. Asthma may lead to death even without pneumothorax. Repeated 
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endotracheal intubations for acute asthmatic attacks may lead to life-threatening tracheal 
stenosis, requiring surgical intervention in the form of tracheostomy to enable adequate upper 
airway patency.6 
 
Inhaled corticosteroids (ICS) are the cornerstone of pharmacotherapy in asthma. They, 
however, can cause local and systemic adverse effects. Local effects include sore throat, 
hoarse voice and oral candidiasis. All patients on inhaled corticosteroids are encouraged to 
rinse out their mouths and brush their teeth after use of ICS, to reduce the above-mentioned 
local effects. The development of oral candidiasis may require treatment with topical 
antifungal therapy.7 
 
Systemic effects of ICS are dose-related, and may be more obvious in patients with co-
existing diabetes mellitus, osteopaenia or established osteoporosis. Patients on high dose ICS 
(i.e. ≥1000mcg beclomethasone dipropionate or equivalent) are at an increased risk of 
developing type 2 diabetes mellitus and its associated complications. Other serious 
complications include the development of tuberculosis and fractures due to osteoporosis.7 
 
1. 2.4 Management 
The four components of asthma management include measures of (1) assessment and 
monitoring, (2) patient education for an efficient partnership in asthma care, (3) identifying 
and controlling environmental factors and co-existing conditions that may affect asthma, and 
(4) pharmacological therapy.5The Global Initiative for Asthma (GINA) advises that asthma 
treatment is adjusted in a continuous cycle. This includes assessment of the asthmatic patient, 
adjusting treatment and reviewing treatment response.8 
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Assessment of asthmatic patients includes a thorough history of symptoms and their 
frequency, a history of co-existing conditions e.g. gastro-oesophageal disorder, and a 
thorough physical examination.8-9Of great importance is to assess the patient's inhaler 
technique and level of adherence. A lung function test, especially forced expiratory volume in 
1 second (FEV1), aids physicians in assessing whether there is disease control, and informs 
them on the need for adjustment in the treatment plans for patients. FEV1, especially if <60% 
predicted, is a modifiable independent risk factor for asthmatic exacerbation.8Patient 
preferencefor the inhaler device (i.e. metered dose inhaler (MDI) with or without a spacer 
device, dry-powder inhaler etc.) is also important, as well as the formulation of a 
comprehensive patient-physician treatment plan.8 
 
Adjustment of treatment is a discussion between patient and physician. Risk factors must be 
identified (e.g. occupational factors affecting disease control, obesity etc.), and modified 
accordingly. Non-pharmacological strategies (i.e. avoidance of identified triggers, weight 
loss, and cessation of smoking) should also be implemented. This requires full compliance 
from the patient to ensure improvement in lung function, as well as reduction of symptoms.8 
 
Treatment response review is dependent on the patient's symptoms, frequency of asthmatic 
exacerbations, drug side-effects and overall patient satisfaction. Objectively, a lung function 
test aids in informing the physician whether disease control is optimal.8-9The Asthma Control 
Test is a questionnaire based tool that provides a numerical score, helping physicians 
determine whether symptoms of patients are well controlled. This test assesses the patient's 
perception of how well their asthma is controlled, as well as the degree that their asthma 
affects their functioning at work and home life. The patient's morning and nocturnal 
symptoms, degree of dyspnoea, and the frequency with which relieving inhaled medication is 
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used, is also assessed during the test. A score above 20 indicates good asthma control, whilst 
that below 15 indicates poor control. A change of more than three points when compared to 
previous scores is regarded as significant and aids physicians in deciding the best next step in 
the management of the patient.  
 
A step-wise approach to asthma treatment is advised by GINA and the South African 
Thoracic Society (SATS).8-9Asthma pharmacological therapy is an evolving combination of 
preferred controller agent and a reliever agent.  GINA uses a 5step approach, starting patients 
on an initial regular dose of ICS adjusted for the level of severity, together with a short-acting 
beta agonist (SABA) on an as-needed basis. Depending on disease control and lung function, 
treatment will be escalated step-wise to include a medium or high dose ICS and a long-acting 
beta agonist (LABA). Leukotriene receptor antagonists and tiotropium are considered as 
alternative additional controller agents. A combined low dose ICS and formoterol inhaler, 
prescribed both for maintenance and reliever therapy, is recommended for patients with 
frequent exacerbations despite other treatment.8 
 
Patient education on the disease itself, inhaler technique, drugs used and their side-effects is 
important for both the physician and patient. This promotes a good open relationship and 
fosters treatment plan adherence. 
 
1. 3 Chronic Obstructive Pulmonary Disease (COPD) 
1. 3.1 Definition 
The Global Initiative for Obstructive Lung Disease (GOLD) defines COPD as a preventable 
and treatable disease. It is associated with significant non-pulmonary effects that add to 
disease severity in patients. It is characterised by airflow obstruction that is often not 
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reversible.10It ismost commonly related to smoking tobacco, and develops later in life. It is a 
progressive disease with an abnormal, poorly regulated inflammatory response of the lungs to 
noxious particles or gases.11 
 
COPD is characterised by dyspnoea, chronic cough and chronic sputum production. 
Spirometry is required to confirm the diagnosis. A post-bronchodilator FEV1/FVC (forced 
vital capacity) ratio < 0.7 confirms airflow limitation, and is highly suggestive of COPD in 
the correct context. Severity classification of COPD depends on the presence of 
FEV1/FVC<0.7 plus an FEV1 ≥80% predicted (GOLD 1, mild COPD), 50-80% predicted 
(GOLD 2, moderate COPD), 30-50% predicted (GOLD 3, severe COPD), and ≤30% 
predicted (GOLD 4, very severe COPD). Very severe COPD is also defined as FEV1<50% 
predicted with chronic respiratory failure.11 
 
1. 3.2 Pathogenesis 
In COPD, the normal inflammatory response is exaggerated with excessive release of 
neutrophils, macrophages and elastases. This results in destruction of large (central) airways, 
the small (peripheral) bronchioles, and the lung parenchyma.11 
 
Smoking causes production of free radicals due to the increased oxidative stress. The 
oxidants released by phagocytes lead to premature cell death or necrosis of exposed cells. 
Accelerated aging and autoimmune mechanisms have also been suggested as having roles in 
the pathogenesis of COPD.11 
 
COPD is often a combination of chronic bronchitis or emphysema. In some cases, patients 
may have a mixture of both diseases. Emphysema is a histopathological diagnosis defined by 
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permanent enlargement of airspaces distal to the terminal bronchioles. Panacinar emphysema 
usually develops in individuals with already a genetic predisposition to alpha 1-antiprotease 
deficiency. Emphysema leads to loss of alveolar surface area resulting in impaired gaseous 
exchange. There is also a decrease in elastic recoil, further worsening airflow limitation and 
narrowing.11 
 
1. 3.3 Complications 
COPD is progressive with worsening respiratory symptoms and poor quality of life. 
Ventilation-perfusion mismatch in the alveoli occurs due to structural damage of lung 
parenchyma and blood vessels. The formation of bullae due to underlying emphysema may 
occur, leading to spontaneous pneumothoraces. 
 
Hypoxaemia leads to pulmonary vasoconstriction and also secondary polycythaemia. The 
latter, in turn, leads to hyperviscosity, increasing the risk of patients developing thromboses. 
This may include deep venous thromboses, pulmonary thrombo-embolic disease and strokes. 
Life-threatening conditions such as coronary artery disease may further complicate the 
management of COPD.11 
 
With impaired ventilation, hypercapnia ensues, causing respiratory acidosis. This contributes 
to hypoxia-induced pulmonary artery vasoconstriction and the development of corpulmonale. 
There is significant strain on the right ventricle of the heart, with severely compromised 
patients developing features of right heart failure. With increasing severity of COPD, 
recurrent exacerbations and repeated chest infections occur frequently. This adds to the 
morbidity of COPD, making it more difficult to improve patient symptoms and quality of life. 
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Domiciliary oxygen is required in severe COPD, with worsening respiratory symptoms, 
declining lung function and intractable respiratory failure.11 
 
1. 3.4 Management 
As for asthma, a full history and thorough physical examination of patients is mandatory. The 
identification of co-existing or emerging systemic manifestations of COPD is important. 
Lung function tests, application of the Modified Medical Research Council Dyspnoea Scale 
and evaluation of exacerbation risk (combined assessment of COPD) aids physicians in 
classifying the severity of COPD adequately and therefore deciding on best treatment plans 
for patients. The aim is to reduce the number of exacerbations, improve quality of life and 
reduce mortality.10-11 
 
The non-pharmacological measures of COPD management include smoking cessation. 
Patient and family education is key, as well as enrolling in support groups. Psychosocial 
support is important in these patients as they are prone to depression. In addition, chest 
physiotherapy and physical therapy with bronchopulmonary hygiene is important. A well-
tolerated exercise programme, as well as vocational rehabilitation is recommended to further 
improve outcomes for patients with COPD.10-11 
 
Pharmacological therapy depends on the combined assessment of COPD.10This is dependent 
on severity of symptoms, FEV1 % predicted and history of exacerbations. These 3 factors 
determine the allocation of patients into class A (low risk of exacerbations, relatively mild 
symptoms), B (low risk of exacerbations, more severe symptoms), C (high risk for 
exacerbations, relatively mild symptoms) or D (high risk of exacerbations, more severe 
symptoms). Patients with mild symptoms and low exacerbation risk require bronchodilator 
9 
 
therapy only, whereas those with more severe symptoms and high exacerbation risk warrant 
additional therapy, e.g. ICS such as budesonide) 10-11 
 
Other therapies used in COPD, which have been proven to be beneficial, include LABA and 
LAMA combinations and phosphodiesterase-4 inhibitors (e.g.roflumilast). Important 
adjunctive management of COPD patients also includes influenza and pneumococcal vaccine 
immunisation, which is appropriate for all stages of COPD, and cardiopulmonary 
rehabilitation. With end stage lung disease, patients are very symptomatic and may require 
domiciliary oxygen therapy. Lung volume reduction surgery and lung transplantation may 
also be considered in patients with severe COPD.10-11 
 
1. 4 The burden of chronic obstructive airway disease in developing countries 
The prescription of inhaled therapy is rising in South Africa due to the exponential rise in the 
incidence of asthma and COPD.1According to a recent report by the GINA, South Africa has 
the world’s 4thhighest asthma death rate among 5to 35 year-olds.  It is estimated that 1.5% of 
the 3.9 million South Africans with asthma, die of this condition annually. 2-3, 12 
 
The latest World Health Organisation (WHO) statistics in 2005 confirmed that approximately 
5% of all deaths globally are estimated to be due to COPD.12-13This correlates to 3million 
deaths annually. The majority of the deaths (90%) are thought to occur in low and middle 
income countries such as South Africa. According to the WHO Global Burden Disease 
Project, COPD will be the 3rdleading cause of death globally by 2030, and will surpass 
HIV/AIDS in Africa.12-13 
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Health services in low-resource countries are poorly adapted to treating chronic 
diseases.14The absence of efficient infrastructure in many countries, and the high cost of 
drugs in low-resource regions mean that many people have limited access to effective 
treatment.14These factors impact negatively on the overall management of patients requiring 
inhaled therapy. Upgrading equipment in hospitals, purchasing effective high-quality drugs at 
low prices, routine training and supervision of health services personnel, and constantly 
evaluating the performance of HCPs are key to positively changing the trajectory of the 
predicted high mortality and morbidity of asthma and COPD.15 
 
1. 5 Disease control and principles of management 
Inhaled bronchodilators and corticosteroids, most commonly administered by MDIs are 
crucial to the management of both asthma and COPD.16When used correctly, they have been 
shown to provide symptomatic relief, prevent acute exacerbations and improve lung function 
in COPD.17In asthma, effective treatment prevents permanent airway obstruction and airway 
hyper-responsiveness.18 
 
MDIs are the most common inhaler devices used for delivery of inhaled therapy globally.16 
They deliver a specific amount of medication, stored in a highly pressurized canister to 
the lungs, in the form of a short burst of aerosolized medicine, self-administered by the 
patient via inhalation. They are, however, technically more difficult to use compared to dry 
powder inhalers, as they require good simultaneous coordination between the handling of the 
device, and respiration. Patients are therefore more prone to make a critical error, when 
compared to patients using less technically difficult inhaler devices.17 
Uncontrolled asthma and COPD are frequent causes of emergency department visits and 
hospital admissions.18Adherence alone is not sufficient unless MDIs are used 
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correctly.19Improper inhaler technique translates to uncontrolled airway disease, increased 
visits to the emergency department and increased hospital admissions.19 
Research has shown that unless patients receive clear instruction, including a physical 
demonstration on the specific type of inhaler they are using, they are unlikely to use them 
correctly.20 No inhaler should ever be prescribed without providing education on its correct 
use. A study in the UK by Hardwell et al.21 showed that 85.6% of 1291 asthmatic patients 
using MDIs failed their first attempt on demonstrating their inhaler technique. 
 
Inhaler technique should be assessed at every visit when symptom control is being assessed.20 
Repeated demonstrations, observation of the patients’ technique, and reinforcement of proper 
inhaler technique are essential.22Research shows that many patients do not receive 
regularcounselling or physical demonstration of correct inhaler technique.17 A study in Zurich 
by Steurer-Steyet al.23showed that only 32% of general physicians felt that they should be 
educating patients, whilst the remaining 68% felt that education should be done only at a 
pulmonologist specialist centre. Physicians prescribing inhaler therapy have been shown to 
have poor compliance with regard to checking and observing patients' inhaler technique.24 
 
Optimal control of asthma and COPD largely depends on the correct use of inhaler devices. 
However, HCPs have been shown to lack basic knowledge and skill in the use of MDIs.25-
26Another study revealed that only 14.2% of physicians could demonstrate MDI technique 
correctly.27HCPs and medical students do not regularly receive formal training in the use of 
inhaler devices.27Findings in these studies highlight the need for regular education 
programmes for all undergraduate medical students, as well as all nurses and physicians.24 
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1. 6 Patients MDI technique and the role of HCPs 
A study by Pothirat et al.28assessed the use of a much easier to use hand-held dry powder 
device (Handi-Haler®), vs. a MDI. The study showed that patients using this device had the 
lowest compliance failure (42.5%). These devices are unfortunately less accessible to the 
South African public health sector due to higher cost. The study emphasised that "face-to-
face" inhalation technique training significantly increased technique compliance for the 
MDI.28 
 
Erickson et al.29 studied a total of 159 patients, directly observing their MDI technique. This 
study showed that more than 82% of patients exhibited inadequate technique (more than 2out 
of 6steps incorrect).Another study showed that although the majority of the patients claimed 
to know how to use inhaler devices, 94.2% committed at least one error in the demonstration 
of their technique.30This suggests discordance between understanding and practice. 
Therefore, it is not sufficient to verbally assess patients' knowledge on the use of inhaler 
devices. Physical demonstrations and direct observation of inhaler technique should be 
mandatory in order to minimize errors and optimize treatment effect.30 
 
1. 7 Patient factors preventing correct MDI technique and the role of HCPs 
Low education level was the single most important factor related to incorrect technique as 
demonstrated by the study done by Pothirat et al.28 (adjusted odds ratio 4.1; 95% CI 1.2–
13.4, p=0.022). With formal training of the patients studied, there was a statistically 
significant decrease in the percentage of incorrect techniques for all devices, including MDIs. 
Individualised training on inhaler technique education, is necessary for all patients, especially 
in patients with low education levels.28 
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HCPs working in the public health sector should be sensitised to the socio-economic and 
educational levels of the patients served. Greater efforts should be made to ensure patients are 
taught correct use of MDIs. 
 
Therefore, this study was conducted to evaluate the knowledge of MDI technique by HCPs 
and final year medical students in Gauteng, South Africa at Chris Hani Baragwanath 
Academic Hospital (CHBAH) and Helen Joseph Hospital (HJH). We also aimed to assess the 
level of compliance by HCPs in checking and demonstrating MDI technique for patients on 
inhaled therapy. 
 
1. 8 Study objectives 
1. To evaluate the HCPs and medical students’ level of knowledge and understanding of 
MDI technique. 
2. To assess the HCPs and medical students’ inhaler technique via a placebo inhaler. 
3. To determine the study participants' perceptions on educating patients on inhaler 
technique and determining whether they routinely check their patients’ inhaler technique 
at every visit. 
 
1. 9 Methods 
The study sample comprised of medical doctors of all ranks, nurses and final year medical 
students at two tertiary hospitals, HJH and CHBAH. The HCPs interviewed were those 
prescribing MDIs in their respective departments, i.e. Department of Accident and 
Emergency Medicine, Department of Internal Medicine and Division of Pulmonology.  
  
14 
 
The study was piloted by inviting target study participants to volunteer to partake in the study 
via an announcement email and formal letter, via the Medical School Student council, all 
Heads of department, Heads of hospitals, and the University of Witwatersrand's student 
coordinator. This recruitment email and letter detailed the background and the objectives of 
the study, and provided pertinent information regarding them as potential study participants. 
Those who voluntarily offered to take part in the study were interviewed. Interviews were 
conducted over a three month period from June 2015 till September 2015, during and after 
working hours in the various medical wards and emergency department areas in the 
abovementioned hospitals. 
 
1. 9.1 Study Sample 
The sample size for the study comprised 195 study participants. It was calculated using the 
followingstandardised formula: 
n= [z2 p (1-p)]  ÷ ∂2 
  =195 
 
 
According to the University of Witwatersrand's Student Administration department, there 
were 184 final year medical students rotating through the Departments of Internal Medicine 
and Emergency Medicine at the time of the data collection. The HumanResource 
Departments of both CHBAH and HJH had in their employment 111 medical registrars, 63 
interns, 2 medical officers and over 100 nurses in the Departments of Internal Medicine and 
the Divisions of Pulmonology; and a total of 7 registrars, 16 interns and 38 medical officers 
in the Department of Emergency Medicine. 
 
=195=195 
Sample size 
p= proportional to outcome (0.15) (10<p<15) 
z= 95% CI (1.96) 
∂= error allowed (0.05=only 5% error allowed) 
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In summary, of the 195 study participants interviewed, 49% (n=96) were medical doctors, 
32% (n=62) were final year medical students and 19% (n=37) were nurses.The proportions of 
the study sample allocated to the different categories of participants reflect the recommended 
proportions as calculated by our sample size formula. Consenting HCPs and final year 
medical students were interviewed during and after working hours at the medical emergency 
department, Pulmonology outpatient department and the medical wards at CHBAH and HJH. 
 
1. 9.2 Data Collection 
Data for this study was collected prospectively over three months from June 2015 till 
September 2015, by administering a questionnaire to the study participants, gauging their 
perceptions, level of knowledge and understanding of MDI technique. Study participants 
were then requested to demonstrate the correct inhaler technique via a placebo inhaler device.  
 
Correct inhaler technique involves 6 manoeuvres in the following sequence: (1) Shaking the 
canister, (2) Exhaling to residual volume, (3) Coordinated simultaneous activation of the 
MDI with initiation of inspiration, (4) Inhaling through the mouth, (5) Slow deep inhalation 
over 5-6 Seconds, (6) Holding of breath for at least 5 seconds prior to exhalation.17 Each of 
the 6 manoeuvres required for correct MDI technique was allocated 1 point. The total for 
each participant was calculated. The investigator was the sole observer for the study. Sterility 
and good hygiene practice was maintained whilst using the placebo inhaler devices. All 
collected data was entered into an Excel database.  
 
 
The following analyses were computed: 
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1. Proportion of medical students who had been taught inhaler technique. 
2. Proportion of HCPs taught inhaler technique as undergraduates at a teaching institution 
vs. those taught only once fully qualified as medical practitioners. 
3. Proportion of participants who regularly educate their patients on inhaler technique and 
check inhaler technique at every visit. 
4. Proportion of study participants able to perform the MDI technique correctly, 
demonstrating all 6manoeuvres in sequence vs. those unable to do so. Since each 
manoeuvre is important in adequate delivery of inhaled medication, any component 
incorrectly performed was regarded as a critical error. The proportion of participants 
performing a critical error for each of the 6 manoeuvreswas calculated. 
 
1. 9.3 Statistical analysis 
Categorical data was analysed using STATA 10.1statistics software package (StataCorp, 
Collage Station, TX), utilizing Fisher's exact test and, in some cases, the Chi Square test. 
Fisher's exact test was favoured for our small sample. 
 
1. 10 Limitations 
The participants interviewed were based in the Public Health Sector only.  
 
1. 11 Ethics 
The study was granted ethics clearance on the 27th September 2013 by the Human Research 
Ethics Committee (Medical) (clearance certificate number M130910). 
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1. 12 Schedule 
 Research 
& protocol 
Protocol 
submission: 
Data 
collection 
Data 
analysis 
Study 
report: 
Study 
submission 
January- 
August 2013 
      
September   
2013 
      
June 2014 – 
July   2015 
      
August 2015- 
September 2015  
      
September -
October 2015 
      
November  
2015 
      
 
1. 13 Funding 
No funding was required. 
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ABSTRACT 
Background 
Uncontrolled asthma and chronic obstructive pulmonary disease (COPD) are frequent causes 
of emergency department visits and hospital admissions. Poor metered dose inhaler (MDI) 
technique is likely a major contributory cause. 
 
Objectives 
This study evaluated study participants' knowledge of MDI technique, and their compliance 
in checking and demonstrating MDI use, to patients prescribed inhaled therapy. 
 
Methods 
A questionnaire was administered to doctors, nurses, and final year medical students at Helen 
Joseph Hospital and Chris Hani Baragwanath Academic Hospital in the Departments of 
Internal Medicine, Emergency Medicine and Pulmonology. Participants’ use of a placebo 
MDI was also evaluated by a scoring system. 
 
Results 
The total sample of 195 participants comprised 130 (67%) females and 65 (33%) males. Of 
these, 133 (68%) were qualified medical staff, and 62 were final year medical students. 
Only 32 (16%) had adequate MDI technique. Over 50% of participants did not demonstrate 
MDI technique to patients, or check their patients' technique. 
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Conclusion 
Health care professionals (HCPs) and final year medical students have poor knowledge of 
inhaler technique and are ill-prepared to teach patients. Also of concern is that the majority 
do not routinely demonstrate or observe patients’ inhaler technique. 
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INTRODUCTION 
 
The prevalence of chronic lung disease is increasing in all parts of the globe. Three hundred 
million people have asthma and 210 million people have chronic obstructive pulmonary 
disease (COPD) worldwide.1-2The prescription of inhaled therapy is rising in South Africa. 
The Global Initiative for Asthma (GINA), estimates that South Africa has over 3.9 million 
asthma sufferers, of which 1.5% die of the condition annually. South Africa has the world’s 
fourth highest asthma death rate among five to 35 year-olds.2-4 
 
The latest World Health Organisation (WHO) statistics in 2005 confirmed that approximately 
5% of all deaths globally are due to COPD.4-5Ninety percent of these deaths are thought to 
occur in low and middle income countries such as South Africa. COPD will be the third 
leading cause of death globally by 2030, and will surpass HIV/AIDS in Africa.4- 5 
 
Inhaled therapy for chronic airway diseases (bronchodilators and corticosteroids), are most 
commonly administered by metered dose inhalers (MDIs). They are crucial to the 
management of both asthma and COPD.MDIs deliver a specific amount of medication, stored 
in a highly pressurized canister to the lungs, in the form of a short burst of aerosolized 
medicine, self-administered by the patient via inhalation. When used correctly with adequate 
dosing, they have been shown to provide symptomatic relief, improve lung function and 
reduce exacerbations.2-4MDIs however, are technically more difficult to use compared to dry 
powder inhalers, as they require good simultaneous coordination between the handling of the 
device, and respiration. Patients are therefore more prone to make a critical error, when 
compared to patients using less technically difficult inhaler devices.6 
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Research shows that many patients do not receive regular counselling or physical 
demonstration of correct inhaler technique.6 Physicians have been shown to have poor 
compliance with checking and demonstrating MDI use to patients prescribed inhaled 
therapy.7 
This study was conducted to evaluate the knowledge of MDI technique by healthcare 
professionals (HCPs) and final year medical students, as well as their compliance in checking 
and demonstrating MDI technique for patients on inhaled therapy. The burden of asthma and 
COPD is on the rise in South Africa, and greater efforts should be made to ensure patients are 
taught correct use of MDIs, and that full compliance to treatment guidelines by HCPs is 
practised. 
 
MATERIALS AND METHODS 
Study population and data collection 
This was a prospective study of HCPs comprising medical doctors and nurses in varying 
ranks, as well as final year medical students working in the Departments of Internal Medicine 
and Emergency Medicine, and the Division of Pulmonology at Helen Joseph Hospital (HJH) 
and Chris Hani Baragwanath Academic Hospital (CHBAH). 
 
A total of 195 study participants volunteered to take part in the study. A questionnaire was 
administered to the study participants gauging their perceptions, level of knowledge and 
understanding of MDI technique. They were then requested to demonstrate correct inhaler 
technique via a placebo MDI. Correct inhaler technique involves 6 manoeuvres in the 
following sequence: (1)Shaking the canister, (2)Exhaling to residual volume, (3) Coordinated 
simultaneous activation of the MDI with initiation of inspiration, (4)Inhaling through the 
mouth, (5) Slow deep inhalation over 5-6 Seconds, (6) Holding of breath for at least 5 
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seconds prior to exhalation. Each of the six manoeuvres required for correct MDI technique 
demonstrated by the participant was allocated one point. Since each manoeuvre is important 
in adequate delivery of inhaled medication, any component incorrectly performed was 
regarded as a critical error. The total for each participant was calculated. All errors were 
documented.  
 
Statistical Analysis 
All collected data was entered into an Excel database.  The categorical data was analysed 
using STATA 10.1statistics software package (StataCorp, Collage Station, TX). Fisher's 
exact test was used to detect statistically significant associations between knowledge of MDI 
use by the different study participants and their compliance in checking and demonstrating 
MDI use to patients. 
 
RESULTS 
Demographics 
Most of the study participants interviewed were female (n=130) (Refer to table 1). There was 
no statistical difference in questionnaire responses or demonstration of MDI technique 
between males and females (p= 0.2298) (Table 1). 
 
A total of 62 final year medical students studying at the University of Witwatersrand and 133 
qualified HCPs were interviewed. A third of the HCPs studied at the University of 
Witwatersrand, whilst 12% studied outside of South Africa. Only 15(11%) of the total HCP 
pool had been qualified for more than 10 years (Table 1). Irrespective of their years of 
experience, rank, or location of undergraduate studies, there was no statistical difference in 
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adequate knowledge of MDI use, as well as compliance in checking and demonstrating MDI 
technique to patients. 
 
HCPs and final year medical students' performance of MDI technique: 
Only 16% of all study participants were able to perform the technique correctly (Figure 1). 
There was no difference on the scores between medical students and HCPs on whether they 
had adequate inhaler technique or not (p=0.5243). 
 
 Factors predisposing to poor knowledge of MDI technique: 
All HCPs and final year medical students interviewed acknowledged the importance of 
having good knowledge of MDI technique. They also showed good insight into how correct 
MDI use significantly impacts disease control and reduction of morbidity and mortality.  The 
study showed that there was no statistical significant difference between final year medical 
students and qualified HCPs (including nurses), on their knowledge of correct MDI use.  
 
A third of study participants were never taught MDI technique. Of the remainder, nearly 50% 
of study participants were taught by lecturers at teaching institutions, whilst less than 20% 
were taught by colleagues (Figure 2).There were no identifiable educational programmes in 
place dedicated to teaching HCPs on MDI technique and treatment protocols for patients on 
MDIs. Similarly, there was lack of placebo MDIs in medical wards, emergency and 
pulmonology outpatient departments.  
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HCPs compliance in checking patients' MDI technique, as well as demonstrating MDI 
technique to patients:  
Fifty-seven percent of study participants declared never observing patients' MDI technique at 
every hospital-related visit (Figure 3). Forty percent of study participants admitted to never 
demonstrating MDI technique to patients (Figure 4). No particular explanations for this were 
offered by the study participants. There was no statistically significant difference between 
those who knew and those who did not know the correct MDI technique with regard to 
whether they demonstrated (p=0.0728) and/or observed their patients’ inhaler technique 
(p=0.1564) (Table 2). 
 
In this study, 45% of all participants felt the responsibility to teach MDI technique was that 
of the treating doctor alone, whilst 21% were of the opinion that this was the nurse’s 
responsibility. 
 
DISCUSSION: 
The immense burden of infectious disease in Sub-Saharan Africa has influenced governments 
to focus their limited recourses on aggressive health campaigns in this area, and neglect non-
communicable diseases such as asthma and COPD. 
 
The increasing burden of COPD and asthma in our country is of great concern. Optimal 
management largely depends on the correct use of inhaler devices by patients, as well as 
repeated demonstrations and observation of patients' inhaler technique by HCPs. 
 
Inadequate knowledge of MDI use by HCPs has been documented globally with similar 
findings in our local study. Plaza Vet al 8showed that only 14.2% of 1514 physicians studied 
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had adequate MDI technique. A South-American based study of 239 physicians, showed that 
only 30% of all participants could demonstrate MDI technique correctly.9The same study also 
demonstrated that 49% of the individuals interviewed in the Pulmonology-Cardiac specialist 
centre, and 19% of the individuals interviewed at a general Internal Medicine centre were 
able to perform inhaler technique correctly.9They postulated that the large difference between 
participants in the specialist centre and the general medical centre was due to the increased 
exposure of patients on inhaler therapy to those working at the specialist centre.9Our study, 
with participants predominantly based in the Internal Medicine wards, Emergency and 
outpatient departments, showed that only 16% of participants had adequate MDI technique. 
Since only a small percentage of study participants were from the Division of Pulmonology 
(1.5%), we could not analyze whether there was a statistically significant difference between 
participants in the specialist unit vs. those in general medicine. However, it is clear that there 
is overall poor knowledge of MDI use amongst HCPs. Contributing to this was the absence of 
placebo MDIs for demonstration of MDI technique in medical wards, emergency and 
pulmonology outpatient departments. 
 
A third of our study participants were never taught MDI technique, with no identifiable 
educational programmes in place for this purpose. Rebuck et al.10were of the opinion that 
postgraduate teaching programmes with regard to MDI use should be determined by the 
needs of day-to-day patient care by HCPs. They conducted a study to determine if structured 
educational intervention vs. none would be sufficient to teach postgraduate physicians inhaler 
skills that can be sustained over a long period. The 8-month follow up of participants in the 
intervention group showed great improvement in the knowledge of MDI use compared to 
their baseline results (59% vs.42%, p<0.05). The intervention group performed better that the 
control group overall (59% vs. 39%, p<0.05).10 
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Twenty percent of participants in our study were taught by fellow colleagues in an informal 
vs. a structured teaching environment. The enforcement of structured teaching in the 
workplace as well as in our teaching institutions will improve knowledge of MDI use. The 
findings of our study should alert all HCPs, teaching institutions, senior personnel and 
managers to prioritise teaching MDI technique so that they may educate their patients, and 
positively impact on disease control. Prioritising teaching MDI technique to HCPs will also 
sensitize them to the importance of compliance with treatment guidelines.  
 
Plaza Vetal.8 found that only 27.7% of 1514 physicians checked their patients' inhaler 
technique when inhaled therapy was being prescribed. A study done in Zurich by Steurer-
Stey et al.11found that 60% of physicians interviewed checked inhaler technique, and a 
significant two-thirds of the study participants expressed that patient education should be 
done at a Pulmonology specialist centre. A survey of patients in a Pulmonology unit in Japan, 
found that only 17.1% of patients were given repeated physical demonstrations of MDI 
technique by a respiratory physician.12Our study found that 57% of study participants 
admitted to never observing patients' MDI technique, whilst 40% admitted to never 
demonstrating MDI technique to patients. Our study also found that having adequate 
knowledge of MDI technique did not translate to the participants complying with checking 
and demonstrating MDI use in real world practice. Also of concern is that this occurred 
despite the majority of study participants’ view that the treating doctor should be the sole 
responsible person for educating patients on MDI use. Our study population was much 
smaller than the above quoted studies, but concurs with their findings. All HCPs involved in 
the care of patients on inhaled therapy should ensure that they are familiar with correct 
inhaler technique and undertake the responsibility to educate their patients on MDI use 
routinely.  
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This obligation is all the more important as we live in a developing country and therefore 
have less access to more user-friendly and costly devices. Our patients also have lower 
education levels and therefore require greater efforts to ensure correct inhaler technique is 
learnt and sustained.  
 
LIMITATION: 
Privately practising nurses, general practitioners, specialist physicians, and pulmonologists 
who see patients using MDIs are not included in this study.  
 
CONCLUSION: 
 
Knowledge of correct MDI technique amongst HCPs and final year medical students was 
poor.  The study also revealed poor compliance amongst HCPs in observing patients' inhaler 
technique and demonstrating correct inhaler technique to patients.  
 
It is our recommendation that all teaching institutions, departments of Internal medicine, 
emergency medicine and affected outpatient departments should have educational 
programmes in place dedicated to teaching correct MDI technique to HCPs and patients. It is 
also our recommendation that HCPs should be familiar with treatment protocols for patients 
on inhaled therapy. 
 
Placebo inhaler devices should be easily accessible at all hospitals to enable HCPs in 
demonstrating MDI technique to patients. 
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Table 1: Demographics of study participants 
Demographics N (%) 
Gender (n=195) 
• Female 130 (67) 
• Males 65 (33) 
HCP Total (n=133) 
• Medical Doctors 96 (72) 
• Nurses 37 (28) 
HCP Years of Experience* (n=133) 
• >10 Years 15 (11,3) 
• 5-10 Years 51 (38,3) 
• <5 Years 67 (50,4) 
Final Year Medical Students 62 
HCP, Health Care Professional.  
*Number of years post undergraduate qualification. 
 
 
 
Table 2: HCPs MDI technique and their compliance in checking and demonstrating 
MDI technique to patients on inhaled therapy 
 Adequate MDI Technique: n (%) 
Inadequate MDI 
technique: n (%) 
Total Number of HCPs (n=32) (n=101) 
Male  15 (47) 35 (35) 
Female 17 (53)  66 (65) 
Demonstrates MDI technique   
Yes 8 (25) 72 (71) 
No 24 (75) 29 (29) 
Checks patients' MDI technique   
Yes 4 (12,5) 53 (52) 
No 28 (87,5) 48 (48) 
HCP, Health Care Professional. MDI, Metered Dose Inhaler. 
 
35 
 
 
Figure 1: Study participants’ MDI technique via a placebo MDI. (Correct MDI technique 
refers to all six manoeuvres adequately performed for effective drug delivery). 
 
 
Figure 2: Participants' MDI technique educator 
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Figure 3: HCPs' observation of patients' MDI technique 
 
 
Figure 4: Demonstration of MDI technique to patients by HCPs. 
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CHAPTER 3: APPENDICES 
 
3. 1 Data Collection Sheet 
 
TITLE: EVALUATION OF THE KNOWLEDGE AND CORRECT USE OF 
METERED DOSE INHALERS BY HEALTH CARE PROFESSIONALS AND 
MEDICAL STUDENTS IN GAUTENG. 
 
1. Sex 
o Male 
o Female 
2. Graduation from Medical School/Nursing College 
o >10 Years ago 
o 5-10 Years ago 
o < 5 Years ago 
o Not applicable 
3. Place of Qualification 
o UCT 
o Walter Sisulu University 
o University of Limpopo (Medunsa) 
o Stellenbosch 
o UKZN 
o Wits 
o UP 
o Other:_____________ 
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4. Department of work 
o Emergency Medicine/Casualty 
o Internal Medicine Department 
o Pulmonology Department 
5. Current Rank 
o GEMP 3/GEMP 4 
o Intern 
o Medical Officer 
o Registrar 
o Nurse: (Rank)_________________ 
6. Were you ever taught the correct technique for using a metered dose inhaler? 
o YES 
o NO 
7. By who were you taught technique? (Only answer if your answer to number "7" is 
"YES") 
o Lecturer at University/Medical School 
o Taught at work by a colleague in the same rank as me 
o Taught at work by a colleague in a higher rank than myself. 
o Taught at work by a colleague in a lower rank by myself 
8. Have you managed a patient prescribed a Metered Dose Inhaler? 
o YES 
o NO 
9. When managing a patient on a Metered Dose Inhaler, do you observe the patient’s inhaler 
technique? 
o Yes, at every visit. 
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o Yes, more than once every 3 months 
o Yes, less than once every 3 months 
o No  
10. When managing a patient on a metered dose inhaler, have you physically demonstrated 
the correct MDI technique, to the patient? 
o Yes, at every visit 
o Yes, more than once every 3 months 
o Yes, less than once every 3 months 
o No 
11. Who do you think is the best person to educate the patient on inhaler technique? 
o The treating medical doctor 
o The pharmacist 
o The nurse 
 
Assessment of the participants' inhaler technique: 
A. Shaking the canister : YES/NO                                              
B. Exhaling to residual volume: YES/NO                                                 
C. Coordinated simultaneous activation of the MDI with initiation of inspiration: YES  / NO    
D. Inhaling through the mouth: YES/NO                                               
E. Slow deep inhalation over 5-6 Seconds: YES/NO                                               
F. Holding of breath for at least 5 seconds prior to exhalation: YES/NO    
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1. Was the participant able to perform all six manoeuvres correctly? 
o Yes 
o No 
2. How many manoeuvres did the participant perform correctly? 
o 1 
o 2 
o 3 
o 4 
o 5 
o 6 
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3. 2 Ethics Clearance Certificate 
 
 
